Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Mallcom (India)'s snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 512.48 | 492.77 | 387.72 |
| Other Liabilities Total | 0.45 | 0 | 6.31 |
| Long Term Debt | 6.24 | 2.51 | 3.71 |
| Common Stock Total | 6.24 | 6.24 | 6.24 |
| Other Current Assets Total | 48.48 | 2.05 | 32.22 |
| Total Assets | 512.48 | 492.77 | 387.72 |
| Current Portof LT Debt/Capital Leases | 114.06 | 0.6 | Not available |
| Cash | 3.75 | 4.19 | 0.24 |
| Total Equity | 318.37 | 298.64 | 237.51 |
| Long Term Investments | 0 | 0 | 0 |
| Retained Earnings(Accumulated Deficit) | 312.13 | 279.72 | 218.59 |
| Total Common Shares Outstanding | 0.62 | 0.62 | 0.62 |
| Property/Plant/Equipment Total-Gross | 0 | 271.42 | 193.7 |
| Tangible Book Valueper Share Common Eq | 510.12 | 478.51 | 380.56 |
| Total Liabilities | 194.11 | 194.13 | 150.21 |
| Total Debt | 120.29 | 115.8 | 92.69 |
| Short Term Investments | 6.25 | 12.72 | 14.54 |
| Cashand Short Term Investments | 10 | 16.91 | 14.78 |
| Total Receivables Net | 86.16 | 119.58 | 95.5 |
| Deferred Income Tax | 4.02 | 2.52 | 1.82 |
| Accounts Receivable-Trade Net | 86.16 | 84.07 | 66.51 |
| Property/Plant/Equipment Total-Net | 224.34 | 202.76 | 133.7 |
| Total Current Liabilities | 183.4 | 189.1 | 138.36 |
| Total Inventory | 138.37 | 147.3 | 107.71 |
| Accounts Payable | 44.12 | 57.42 | 39.45 |
| Other Currentliabilities Total | 25.22 | 17.88 | 9.93 |
| Total Long Term Debt | 6.24 | 2.51 | 3.71 |
| Intangibles Net | 0.05 | 0.05 | 0.04 |
| Other Long Term Assets Total | 0 | 0 | Not available |
| Note Receivable-Long Term | 5.08 | 3.98 | 3.52 |
| Total Current Assets | 283.01 | 285.98 | 250.46 |
| Accumulated Depreciation Total | Not available | -68.66 | -60 |
| Accrued Expenses | Not available | 0.51 | Not available |
| Prepaid Expenses | Not available | 0.15 | 0.24 |
| Additional Paid-In Capital | Not available | 12.68 | 12.68 |
| Notes Payable/Short Term Debt | Not available | 112.69 | 88.98 |
Debt 5Yr CAGR %16.17
Operating Margin 12m8.91
Operating Margin 5y Avg10.87
Net Profit Margin 12m5.57
Net Profit Margin 5y8.68
Dividend Yield %0.29
Price to Sale Ratio1.19
Overall RiskBalanced risk
Board Risk43.17
ConsensusBuy
Consensus score2.00
Analyst opinions1
Strong Sell count0
Sell count0
Hold count0
Buy count1
Strong Buy count0
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Lenskart Solutions | INR 555.8 | 96,656.06 | 181 | — |
| Poly Medicure | INR 1,693.45 | 17,152.35 | 52.1 | — |
| Laxmi Dental | INR 217 | 1,196.47 | 35.63 | — |
| One Global Service Provider | INR 594 | 1,160.86 | 16.95 | — |
| Hemant Surgical Industries | INR 384.75 | 559.33 | 26.04 | — |
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Mallcom announces Rs.100 cr. investment, Expands PPE Capabilities With Sanand Facility The Textile Magazine
Enterprise value to revenue forward of Mallcom (India) Ltd. – NSE:MALLCOM TradingView
Mallcom (India) Ltd. Actuals & Estimates (NSE:MALLCOM) TradingView
Mallcom (India) Dividend Payout History Equitymaster
Mallcom (India) Ltd Technical Momentum Shifts Amid Mixed Market Signals Markets Mojo
Mallcom (India) consolidated net profit declines 78.84% in the March 2026 quarter Business Standard
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Mallcom (India) Limited is an India-based company, which is engaged in the integrated manufacturer, exporter and distributor of a range of personal protective equipment (PPE). The Company operates through Industrial Safety Products segment. Industrial Safety Products business includes leather hand gloves, industrial work garments, seamless knitted gloves, leather shoe upper, safety shoes, and nitrile dipped gloves. Its Body products include disposable workwear, denim workwear, flame retardant workwear, heavy workwear, HI vis workwear, light workwear, multinorm workwear, occupational workwear, rainwear, soft shell & polo workwear, sustainable workwear, thermal workwear, women's workwear, and feet. The Company serves various industries, including automobile and auto ancillary, agriculture, biotechnology, glass and ceramic, chemical and paint, infrastructure, healthcare, defense and security, logistics and transportation, manufacturing, metal and mining, and pharmaceuticals.
Mallcom (India) has the symbol MALLCOM and ISIN - INE389C01015.
Mallcom (India) is currently trading at INR 931.60.
Mallcom (India) has a year high of INR 1,529.50 and a year low of INR 900.00.
Mallcom (India) has a market capitalization of INR 642.08 crore.
Mallcom (India) has a P/E ratio of 19.49.
Mallcom (India) has a dividend yield of 0.29%.
Mallcom (India) has revenue of INR 539.61 crore, net income of INR 30.04 crore, and EPS of INR 48.15.
Mallcom (India) has a book value of INR 510.12.
Mallcom (India) has a debt-to-equity ratio of NA.
Mallcom (India) has a price-to-book ratio of 1.83 and a price-to-sales ratio of 1.19.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.